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Adverse health effects in individuals of all ages
have been linked to exposure to ambient air
contaminants (American Academy of
Pediatrics 2004; Jerrett et al. 2005; Pope et al.
2004a). Cardiovascular and respiratory mor-
bidity and mortality are the most common
health effects associated with exposure to
ambient air contaminants, but other effects
that have been linked epidemiologically
include adverse fetal development (Dejmek
et al. 2000; Liu et al. 2003; Perera et al. 2003)
and cancer (Boffetta 2004; Cordier et al.
2004; Vineis et al. 2004). The actual mecha-
nism by which these effects may be produced
is frequently unclear, although a substantial
body of work has elucidated the relationship
between airborne particulate matter (PM) and
vasoconstriction (Barclay et al. 2005; Brook
et al. 2004; Pope et al. 2004b). 
The possibility that ambient air contami-
nants may be involved in endocrine disruption
is an intriguing question (Rogan and Ragan
2003). Several studies have demonstrated the
ability of organic contaminants found in ambi-
ent air to activate intracellular receptors that
are the entry points to signaling pathways
implicated in endocrine disruption (Clemons
et al. 1998; Vinggaard et al. 2000; Vondracek
et al. 2004). In addition to epidemiologic stud-
ies that have demonstrated an association
between exposure to ambient air contaminants
and endocrine-disruptive effects (Jedrychowski
et al. 2004; Perera et al. 2003, 2004), in vivo
studies have shown reproductive effects in
rodents exposed via inhalation to diesel
exhaust (Furuta et al. 2004; Takeda et al.
2004; Watanabe and Kurita 2001).
Most toxicologic research examining
ambient organic air contaminants has focused
on contaminants sorbed to PM, yet the spe-
cific role that these organic contaminants may
play in the biologic effects of ambient air con-
taminants remains unknown. A large fraction
of many airborne chemical classes is present in
part or almost exclusively in the gas phase,
which has received little if any characterization
for biologic activity.
In addition to the substantial challenge of
determining the mechanisms underlying health
effects from exposure to ambient air, it is
important to recognize that not all of the
potentially biologically active constituents of
organic air contaminants have been isolated
and identified. Urban air contains a complex
mixture of constituents, of which only a small
fraction has been identified (Rogge et al. 1993).
Transformation products are rarely analyzed or
considered in mass-balance analyses of the
activity of organic extracts of ambient air
contaminants in receptor-activation assays,
even though they exhibit biologic activity
(Fertuck et al. 2001; Machala et al. 2004;
Wang et al. 2003). Further, exposure to these
contaminants is variable and depends on such
factors as the proximity to point or nonpoint
sources, spatial and temporal variation, and
atmospheric conditions.
To address the influence of spatial and
temporal factors and to examine the potential
biologic activity of the gas phase of organic
contaminants in ambient air, we subjected
extracts of particulate- and gas-phase ambient
air samples, collected from both urban and
rural locations in two seasons (winter and sum-
mer) over 2 years, to estrogen receptor (ER)
chemically activated luciferase expression
(CALUX) and aryl hydrocarbon receptor
(AHR) CALUX cell bioassays. The CALUX
assay is a rapid, sensitive, and well-validated
method of assessing the capacity of either mix-
tures or single compounds to bind and activate
the ER and AHR signaling pathways (Denison
et al. 2004; Houtman et al. 2004; Rogers and
Denison 2000). Previous studies have demon-
strated that organic extracts of the particulate
phase of ambient air contaminants are capable
of activating these pathways in different in vitro
assays, including CALUX (Hamers et al.
2000), but to our knowledge no study has yet
examined the activity of gas-phase extracts.
Materials and Methods
Collection and preparation of air samples.
Urban air samples were collected in downtown
Toronto, Ontario, Canada, and rural air
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Several adverse health effects, such as respiratory and cardiovascular morbidity, have been linked
to exposure to particulate matter in ambient air; however, the biologic activity of gas-phase ambi-
ent organic air contaminants has not been examined as thoroughly. Using aryl hydrocarbon recep-
tor (AHR)–based and estrogen receptor (ER)–based cell bioassay systems, we assessed the
dioxin-like and estrogenic activities of gas-phase organic ambient air contaminants compared with
those of particulate-phase contaminants using samples collected between seasons over 2 years from
an urban and a rural location in the Greater Toronto Area, Canada. The concentration of the sum
(Σ) of polycyclic aromatic hydrocarbons, which was highest in the gas phase, was 10–100 times
more abundant than that of Σpolychlorinated biphenyls, Σnitro-polycyclic aromatic hydrocarbons,
and Σorganochlorine pesticides, and 103 to 104 times more abundant than Σpolychlorinated
dibenzo-p-dioxins/dibenzofurans. Gas-phase samples induced significant AHR- and ER-dependent
gene expression. The activity of the gas-phase samples was greater than that of the particulate-
phase samples in the estrogen assay and, in one case, in the AHR assay. We found no strong asso-
ciations between either summer or winter seasons or urban or rural locations in the relative
efficacy of the extracts in either the ER or AHR assay despite differences in chemical composition,
concentrations, and abundance. Our results suggest that mechanistic studies of the health effects
of ambient air must consider gas and particulate phases because chemicals present in both phases
can affect AHR and ER signaling pathways. Key words: AHR, air pollution, CALUX, complex
mixtures, endocrine disruption, ER, PAH. Environ Health Perspect 114:697–703 (2006).
doi:10.1289/ehp.8496 available via http://dx.doi.org/ [Online 29 December 2005]
samples in Egbert, Ontario, Canada, 75-km
northeast of Toronto. The downtown site was
on the roof of a three-story building located
on a heavily traveled street. The rural site was
located at ground level at Environment
Canada’s Centre for Atmospheric Research.
Samples were collected simultaneously at both
sites for each sampling period. There were
four sampling periods: 20–24 March 2000,
6–16 July 2000, 3–13 March 2001, and
31 July to 8 August 2001. Temperatures dur-
ing the sampling periods were approximately
10°C for the winter (March) and 25°C for the
summer (July–August). High-volume air sam-
plers fitted with polyurethane foam plugs and
Teflon filters were used to collect particulate-
and gas-phase samples of ambient air.
Samplers were run at a flow rate of approxi-
mately 1,000 m3 per 24 hr. Samples were
composited to represent the equivalent of
approximately 8,000 m3 of air taken over
5–10 days (in shorter sampling periods, two
air samplers were deployed simultaneously).
Details of the extraction and cleanup of
the air samples were reported previously by
Dann (1998). Extracts were split, with 50%
going to bioassays and 25% going to chemical
analysis of polychlorinated dibenzo-p-dioxins/
dibenzofurans (PCDDs/PCDFs) and nitro-
polycyclic aromatic hydrocarbons (N-PAHs),
and 25% going to chemical analysis of PAHs,
polychlorinated biphenyls (PCBs), and organo-
chlorine (OC) pesticides. PAHs were quantified
by capillary-column gas chromatography/
low-resolution mass spectrometry (GC/MS),
whereas PCBs and OC pesticides were quanti-
fied by gas chromatography with electron
capture detection (Harner et al. 2004).
PCDDs/PCDFs and N-PAHs were quantified
by high-resolution GC and high-resolution MS
(Dann 1998). Concentrations were corrected
for recoveries only for the PCDDs/PCDFs.
Concentrations were not corrected for blanks
because analyte concentrations in both method
and field blanks were typically < 5% of those in
the test samples.
Reporter cell lines. The AHR reporter cell
line H1L6.1c1, a murine hepatoma cell line
(Han et al. 2004), and the ER reporter cell
line BG1Luc4E2, a human ovarian carcinoma
cell line (Rogers and Denison 2000), are sta-
bly transfected cell lines in which luciferase
expression is regulated by AHR (H1L6.1c1)
or ER (BG1Luc4E2). Cell lines were main-
tained as described previously by Hodge et al.
(2003) and Rogers and Denison (2000).
Treatment of H1L6.1c1 cells. Cells were
plated at a density of 6 × 104 cells/well in
12-well plates. After 24 hr, cells were treated
with growth medium [α-minimal essential
medium (αMEM) plus 10% fetal bovine
serum (FBS); media control], growth medium
plus 0.1% dimethyl sulfoxide (DMSO;
solvent control), reference agonist [10–7 M
β-naphthoflavone (β-NF)], or various dilu-
tions of the air sample extracts. After 4 hr, the
cells were lysed, and luciferase activity assessed
as previously described (Garrison et al. 1996)
using a commercially available luciferase assay
(Promega, Madison, WI, USA). A 4-hr expo-
sure was chosen to minimize any effect of cel-
lular metabolism on the chemical composition
of the extract (Windal et al. 2005). Luciferase
activity was expressed as relative light units per
milligram of cell lysate protein.
Treatment of BG1Luc4E2 cells. Cells
were plated at a density of 6 × 104 cells/well
in 12-well plates. After 24 hr, the medium
was changed to estrogen-reduced medium to
minimize the basal expression of luciferase.
Estrogen-reduced medium consisted of
αMEM without phenol red (Gibco BRL,
Burlington, ON, Canada) and 10% charcoal-
stripped FBS (Hyclone Inc., Logan, UT,
USA). After 48 hr, cells were treated with
17β-estradiol (E2)-reduced medium alone
(media control), E2-reduced media plus 0.1%
DMSO (solvent control), reference agonist
(10–10 M E2), or various dilutions of air sam-
ple extracts. At 72 hr, the cells were harvested
and luciferase activity assessed as described
(Rogers and Denison 2000).
Statistical analyses. In all cases, protein
concentration was determined by the method
of Bradford (1976). Curve fitting was per-
formed using GraphPad Prism software (ver-
sion 3.0; GraphPad Software, San Diego, CA,
USA). Principal components analysis (PCA)
Klein et al.
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Figure 1. Chemical composition of the ambient air extracts from air samples collected March 2000–July
2001. Abbreviations: rur, rural sample; urb, urban sample. (A) PAHs. (B) PCBs. (C) N-PAHs.
(D) PCDDs/PCDFs. (E) OC pesticides. See “Materials and Methods” for details of experiments. 
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was performed using SPSS version 11.0 (SPSS,
Chicago, IL, USA).
Results and Discussion
Chemical analysis. The concentrations of the
sum (Σ) of PCDDs/PCDFs (ΣPCDDs/
PCDFs; picograms per cubic meter of air),
ΣPAHs (nanograms per cubic meter), ΣPCBs
(nanograms per cubic meter), ΣN-PAHs
(nanograms per cubic meter) and ΣOC pesti-
cides (nanograms per cubic meter) in each of
the 12 air samples are shown in Figure 1. The
PAHs were the most abundant of all the
chemical classes we analyzed and were present
at concentrations 103 to 104 times greater
than ΣPCDDs/PCDFs, and 10–100 times
greater than ΣPCBs, ΣN-PAHs, and ΣOC
pesticides. These concentrations are similar to
those previously reported for other urban cen-
ters of North America and Western Europe
(Currado and Harrad 2000; Dimashki et al.
2001; Lohmann et al. 2000).
As expected, concentrations of ΣPAHs,
ΣPCDDs/PCDFs, ΣN-PAHs, and ΣPCBs in
particulate- and gas-phase samples were higher
in urban than in rural locations for July sam-
ples because of the geographic concentration
of emission sources in the urban location. The
absence of an urban–rural pattern in total OC
pesticide concentrations may be explained by
long-range transport of “legacy” pesticides
long banned in North America [e.g., DDT
(dichlorodiphenyltrichloroethane)] as well as
agricultural activities and atmospheric trans-
port of current-use pesticides such as endosul-
fan and lindane (Gingrich et al. 2001; Harner
et al. 2004).
Concentrations of ΣPAHs and ΣPCDDs/
PCDFs were similar between March and July
samples, indicating temporally consistent
sources such as mobile and stationary combus-
tion (Lee et al. 2003). ΣOC pesticide concen-
trations were also similar with season, consistent
with regional and long-range transport (Harner
et al. 2004). Contrary to expectation, ΣPCBs
did not show seasonal differences (Halsall et al.
1995), suggesting that regional atmospheric
transport may be the source. ΣN-PAH concen-
trations were greatest in July, which suggests
increased formation of these chemicals resulting
from photochemical processes (Atkinson and
Arey 1994).
The compounds we analyzed have a
wide range of volatilities and varied in their
distribution between gas and particulate
phases. With the exceptions of ΣPCDDs/
PCDFs and March ΣN-PAHs, most com-
pounds were found in gas-phase samples. Not
including the PCBs, the five most abundant
compounds and congeners in the particulate-
and gas-phase samples accounted for 60–95%
of the total amount of compound in each class
(Table 1). Also, there was no overlap between
the most abundant PCBs in the particulate
phase and the most abundant PCBs in the gas
phases, whereas the most abundant com-
pounds for each of the other chemical classes
were similar in both gas and particulate phases.
However, the overall concentration of PAHs
and OC pesticides were 10 times greater in the
gas phase than in the particulate phase, and the
reverse was true for PCDDs/PCDFs.
We performed PCA to identify major
contributions to variance in the chemical
composition of the samples. Data were
autoscaled to unit variance, and the analysis
included only those compounds/congeners
present in both gas and particulate phases. As
shown in Figure 2A, the first two components
accounted for 87% of the variance for PAHs.
Three clusters are evident in the plot for
PAHs: all gas-phase samples in the upper left
quadrant, which separate from urban particu-
late phase samples along PC1, and rural par-
ticulate phase samples along PC2. Within the
cluster of gas-phase samples, July versus
March samples separated along PC2. The sim-
ilarity of urban and rural gas-phase samples
relative to their respective particulate-phase
samples is likely because of the greater trans-
port distance of gas-phase versus particulate-
phase PAHs.
The concentrations of the gas-phase
PAHs anthracene, acenaphthene, fluorene,
and phenanthrene distinguished the gas phase
from urban and rural particulate phases.
Variance in rural particulate-phase samples
was explained by concentrations of chrysene,
pyrene, and fluoranthene, whereas the vari-
ance in urban particulate-phase samples was
explained by triphenylene, benzo[a]fluorene,
and benzo[b]fluorene.
Samples in the PCA analysis of the PCB
data clustered in the same pattern as for
PAHs: all gas phase, urban particulate phase,
and rural particulate phase (Figure 2B). The
first two components accounted for 60% of
the variance among samples. The rural 
particulate-phase July 2000 sample was
excluded because of the high-number con-
geners that were below detection. Variance of
the gas-phase samples was explained by trichlo-
rinated and tetrachlorinated congeners (e.g.,
PCB congeners 16/32, 49, 70/76), whereas
variance in urban particulate-phase samples
was explained by hexachlorinated and hepta-
chlorinated congeners (e.g., PCB congeners
138, 183, 170).
Estrogenic activity of gas-phase air contaminants
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Table 1. Mean percentage of sample composed of the five most abundant compounds listed in descending
order.
Compounds Gas phase Particulate phase
PAHs 95% of total: phenanthrene, 60% of total: benzo[g,h,i]perylene, 
fluoranthene, pyrene, fluorene, benzo[b]fluoranthene, fluoranthene, 
anthracene, 2-methyl fluorine pyrene, indenol[1,2,3-c,d]pyrene
PCBs 13% of total: PCB congeners 8% of total: PCB congeners 138, 
52, 95, 31, 18, and 101 153, 8/5, 180, 149
N-PAHs 99% of total: 9-nitroanthracene, 100% of total: 9-nitroanthracene, 
2-nitrofluoranthene, 1-nitropyrene, 2-nitrofluoranthene, 1-nitropyrene, 
9-nitrophenanthrene, 7-nitrobenz[a]anthracene,
7-nitrobenz[a]anthracene 6-nitrobenzo[a]pyrene
PCDDs/PCDFs 88% of total: 2,3,7,8,-tetraCDF, 94% of total: OCDD, 1,2,3,4,6,7,8- 
octaCDD, 1,2,3,4,6,7,8,-hepta-CDD, heptaCDD, 1,2,3,4,6,7,8-heptaCDF, 
1,2,3,4,6,7,8,-heptaCDF, 2,3,4,7,8,- octaCDF
pentaCDF, 1,2,3,4,7,8-hexaCDF
OC pesticides 82% of total: endosulfan, γ-HCH, 82% of total: endosulfan, p,p´-DDT, 
p,p´-DDE, dieldrin, α-HCH p,p´-DDE, dieldrin, γ-HCH
Abbreviations: CDD, chlorinated dibenzodioxin; CDF, chlorinated dibenzofuran; DDE, dichlorodiphenyldichloroethylene;
HCH, hexachlorcyclohexane. 
Figure 2. PCA of PAH and PCB chemical data. Abbreviations: part, particulate; rur, rural sample; urb, urban
sample. (A) PAHs; the first two components accounted for 87% of the variance. (B) PCBs; the first two
components accounted for 60% of the variance. 
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Biologic activity of air samples in cells in
culture. Both gas- and particulate-phase
extracts induced significant activation of ER-
and AHR-dependent luciferase gene expres-
sion. The distinctions in chemical composition
between phase, site, and season were not
reflected in the results of the CALUX assays,
suggesting the aggregate biologic activity of
the different congeners in each extract is
similar.
As described above, PAHs were the most
abundant of the chemical classes analyzed,
present at concentrations approximately three
to four orders of magnitude greater than
those of the potent AHR agonists PCDDs/
PCDFs and one to two orders of magnitude
greater than concentrations of the PCBs.
These relative amounts are an important fac-
tor in the ultimate potency of these extracts.
Less than additive, weak agonist interactions
are observed with mixtures in in vitro AHR
assays, where the concentration of potent ago-
nists is significantly lower than those of more
moderate agonists (Safe 1997–1998). Thus,
the activity of each extract is influenced by
these interactions and reflects the composi-
tion of the PAH fraction rather than the
PCDD/F and PCB fractions.
AHR reporter cell line. Figure 3 shows the
results of extracts in the H1L6.1c1 cell line,
grouped by date and site. Results are normal-
ized to protein content in cell extracts and
expressed as a percentage of the response in
the cell line to 10–7 M β-NF, which repre-
sented the 95th percentile of the β-NF dose–
response curve and 100% of the response to
10–9 M 2,3,7,8-tetrachlorodibenzo-p-dioxin
(data not shown).
All extracts induced luciferase expression
in a concentration-dependent manner. In
most cases, upper plateaus of response were
observed, allowing for comparison of efficacy
between extracts. In all cases, gas-phase
extracts were less efficacious than the corre-
sponding particulate-phase extracts for the
same sampling dates and locations. If the
activity of the extracts was driven by the
concentration of PAHs, the higher activity
of the particulate-phase extracts could be
explained by the relatively higher affinity for
the AHR of PAHs in this fraction, compared
with those in the gas phase (Table 1)
(Piskorska-Pliszczynska et al. 1986; Till et al.
1999). Given the relatively large amounts of
PAHs in the extracts, we expect this class of
contaminants to be at least partly responsible
for the AHR-dependent inducing activity
observed. Moreover, because of the short
duration (4 hr) of the cells’ exposure to the
mixture, the PAH concentrations would not
have been diminished by metabolism.
Ranking the relative potency of the
extracts was challenging. The concentration–
response curves were not parallel, and the
maximum responses of some extracts
exceeded the response to a maximally induc-
ing concentration of 10–7 M β-NF. The rea-
sons for these results are not known; however,
others have reported this phenomenon.
Inhibition of AHR degradation results in
superinduction of AHR-inducible genes (Ma
2002). Alternatively, activation of other sig-
naling pathways may augment AHR function
(Seidel et al. 2001) or result in a synergistic
Klein et al.
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Figure 3. Dose–response curves for AHR-responsive cells treated with varying concentrations of air
extracts (m3 air/well) of gas-phase and particulate-phase ambient air samples. (A) Urban sample, March
2000. (B) Urban sample, March 2001. (C) Urban sample, July 2000. (D) Urban sample, July 2001. (E) Rural
sample, July 2000. (F) Rural sample, July 2001. Activity is expressed as percentage of the response relative
to 10–7 M β-NF. Data represent mean ± SD from three separate experiments. Dose–response curves were
generated using GraphPad Prism software. 
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Gas phase
Air (m3/well, log10) Air (m3/well, log10)
Air (m3/well, log10) Air (m3/well, log10)
Air (m3/well, log10) Air (m3/well, log10)
Table 2. Apparent potency of samples in AHR reporter gene assay at different induction levels and maxi-
mum induction, in descending order.
20% of 50% of Efficacy
Sample 10–7 M β-NF (m3) Sample 10–7 M β-NF (m3) Sample (% of β-NF)
urb part Mar 00 0.01 urb part Mar 00 0.04 urb part Mar 00 No plateau
urb part Jul 01 0.02 urb part Jul 01 0.08 rur part Jul 00 No plateau
urb part Jul 00 0.02 urb part Jul 00 0.09 rur part Jul 01 129
urb gas Mar 00 0.03 rur part Jul 01 0.14 urb part Jul 00 110
rur part Jul 01 0.04 urb part Mar 01 0.18 urb part Jul 01 92
urb part Mar 01 0.04 rur Jul part 00 0.28 urb part Mar 01 87
urb gas Jul 01 0.06 urb gas Jul 01 0.58 urb gas Jul 01 60
rur part Jul 00 0.09 urb gas Mar 00 0.66 urb gas Mar 00 58
urb gas Jul 00 0.19 rur gas Jul 00 5.00 rur gas Jul 00 58
rur gas Jul 00 0.41 urb gas Jul 00 6.32 urb gas Jul 00 52
rur gas Jul 01 0.9 rur gas Jul 01 —a urb gas Mar 01 48
urb gas Mar 01 1.02 urb gas Mar 01 —a rur gas Jul 01 33
Abbreviations: part, particulate; rur, rural sample; urb, urban sample.
aSample did not elicit 50% of the activity of 10–7 M β-NF.
Estrogenic activity of gas-phase air contaminants
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increase in AHR-dependent gene expression
(Chen and Tukey 1996; Long et al. 1998).
The complex mixture that constitutes the gas-
and particulate-phase air extracts could be
activating any or all of these mechanisms.
The lower efficacy of gas-phase extracts
compared with particulate-phase extracts was
the only statistically significant observation
(unpaired t-test, p = 0.005) between origin of
sample and biologic activity. Similar analyses
between seasons or locations and efficacy were
not statistically significant despite the separa-
tion of rural and particulate-phase samples in
the PCA. The lack of association between loca-
tion and efficacy has been reported by others
(Binkovà et al. 1999).
It was not possible to calculate a true EC50
(concentration which produced 50% of the
maximum) value for all samples; therefore, to
aid comparison of one sample with another,
Table 2 shows the concentration of air that
elicited 20% and 50% of the response to
10–7 M β-NF in the AHR reporter cell line.
Using these values as a measure of relative
potency, Table 2 demonstrates that maximum
response to a sample can differ for samples with
similar relative potency. For example, the urban
particulate extract of March 2000 and the
urban particulate extract of July 2000 have sim-
ilar activity at 20% or 50% of the response to
10–7 M β-NF, yet the maximum activity of
each sample is quite different. Similarly, the
rural particulate extract of July 2000 has similar
relative potency to the urban gas-phase extract
of July 2001, yet the maximum responses are
quite dissimilar. In contrast, the rural gas-phase
extract of July 2001 and the urban gas-phase
extract of March 2001 are similar in all respects.
These divergent patterns of concentration
response are not unexpected. Ligand potency
depends not only on the affinity of the receptor
for the ligand but also on the ability of the lig-
and–receptor complex to bind additional tran-
scription factors and elicit a response
(Hestermann et al. 2000; Kohn and Melnick
2002). The dose–response curve for each
extract is the outcome of the complex interplay
of these events. The net effect, that is, the dose–
response curve, will depend on the relative ago-
nist–antagonist properties, which are different
for each sample in this study (Table 1).
ER reporter cell line. Results of experi-
ments using the extracts in the ER reporter
cell line BG1Luc4E2 are shown in Figure 4,
where concentration–response data are
grouped by site and date. Results were nor-
malized to protein content in cell extracts and
expressed as a percentage of the maximum
response of 10–10 M E2.
In contrast to the results obtained in the
AHR reporter cell line, the activity of gas-phase
extracts, judged by magnitude of induction,
frequently exceeded that of particulate-phase
extracts in the ER reporter cell line (see, e.g.,
the gas- vs. particulate-phase extracts for urban
March and July 2000, Figure 4A,C). This
result is of interest because, as described above,
most research examining the activity of organic
contaminants of ambient air has focused on
particulate-phase extracts. Our results indicate
that the gas phase may have activity equal or
greater than that of the particulate phase in an
ER reporter assay. Table 3 reports the concen-
tration of air at which 50% and 20% of the
Figure 4. Dose–response curves for ER-responsive cells treated with varying concentrations of air extracts
(m3 air/well) of gas-phase and particulate-phase ambient air samples. (A) Urban sample, March 2000.
(B) Urban sample, March 2001. (C) Urban sample, July 2000. (D) Urban sample, July 2001. (E) Rural sample,
July 2000. (F) Rural sample, July 2001. Activity is expressed as percentage of the response to 10–10 M estra-
diol. Data represent mean ± SD from three separate experiments. Dose–response curves were generated
using GraphPad Prism software. 
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Table 3. Apparent potency of samples in ER reporter gene assay at different induction levels, in descending
order.
20% of 50% of
Sample 10–10 estradiol (m3) Sample 10–10 estradiol (m3)
urb gas Jul 00 0.39 urb gas Jul 00 1.26
urb gas Mar 00 0.62 urb gas Mar 00 2.25
urb gas Jul 01 1.90 rur gas Jul 01 6.23
rur gas Jul 01 2.27 rur part Jul 00 6.92
rur part Jul 00 2.32 urb gas Jul 01 7.65
urb gas Mar 01 2.90 urb gas Mar 01 9.48
rur gas Jul 00 3.97 urb part Mar 00 11.23
urb part Mar 00 4.58 rur gas Jul 00 12.45
urb part Mar 01 5.28 urb part Mar 01 12.50
urb part Jul 00 7.26 rur part Jul 01 —a
rur part Jul 01 12.25 urb part Jul 00 —a
urb part Jul 01 18.47 urb part Jul 01 —a
Abbreviations: part, particulate; rur, rural sample; urb, urban sample.
aSample did not elicit 50% of the activity of 10–10 estradiol.
activity of the reference standard was induced
in the ER reporter cell line. As observed for
AHR responses, there was no apparent differ-
ence in activity between rural and urban sites
or between seasons.
Possible sources of estrogenic activity in the
ambient air extracts include PAH, PCBs,
N-PAHs, and OC pesticides. Various PAHs
and PCBs and their metabolites (Fujimoto et al.
2003; Furuta et al. 2004; Pliskova et al. 2005)
as well as OC pesticides (Kojima et al. 2004)
are reported to be estrogenic. Complicating
interpretation of the estrogenic activity, how-
ever, is the fact that some PAHs and PCBs and
their metabolites also exhibit antiestrogenic
activity (Arcaro et al. 1999; Connor et al. 1997;
Kramer et al. 1997).
Cellular metabolism in the BG1Luc4E2
cell line includes the cytochrome P450
enzymes, which yield hydroxyl metabolites of
PCBs, PAHs, and N-PAHs. Hydroxylated
PCBs have been shown to exhibit estrogenic
activity in ER-CALUX assays and, in some
cases, are more potent than the parent PCBs
(Layton et al. 2002; Nesaretnam et al. 1996).
Hydroxy-PAHs have also been shown to bind
and/or activate ER (Charles et al. 2000; Fertuck
et al. 2001). Additional classes of estrogenic
chemicals not analyzed in our studies but likely
to be present in the extracts include phthalate
esters, which have been shown to be weak ER
agonists (Zacharewski et al. 1998).
Conclusions
To our knowledge, this is the first study to
examine the dioxin-like and estrogenic activity
of organic extracts of the gas phase of ambient
air. Our results not only suggest that mecha-
nistic studies of the health effects of ambient
air need to consider both phases as having the
potential to induce and/or inhibit AHR and
ER signaling pathways but also suggest that the
relationship between chemical composition
and biologic activity is highly complex. Two of
the expected factors driving variation in chemi-
cal composition between our samples (phase
and location) were mathematically detectable
in the PCA. However, the results for urban
versus rural location were not discernible in the
results of the highly sensitive CALUX bioas-
says. This may be due to unidentified com-
pounds, nonlinearity between the magnitude
of differences in chemical concentration and
the response in the CALUX assay, interactions
between chemicals and cellular factors, the
presence of both agonists and antagonists in
the sample, or, more likely, some combination
of the above factors.
There is another possibility, however. The
fact that an in vivo study comparing the
biologic activity (AHR mediated) of organic
extracts of PM10 along an urban–rural gradient
and between seasons also did not find signifi-
cant locational differences, despite differences
in ambient air concentrations of AHR or ER
agonists (Binkovà et al. 2003), may be because
the concentration response of exposure to mix-
tures of AHR agonists is not sigmoidal due to
the impact of weak agonist interactions (Kohn
and Melnick 2002). That is to say, the biologic
effects of exposure to mixtures of relatively
lower concentrations may not be exceeded by
those of exposure to mixtures at relatively
higher concentrations.
Interestingly, seasonal and locational differ-
ences have been observed in some epidemio-
logic studies comparing different biomarkers
and end points with ambient air composition
(Dejmek et al. 2000; Perera et al. 2003). The
absence of any similar finding in this in vitro
study may be due to the high sensitivity of the
CALUX assay and its “remoteness” as a recep-
tor assay looking at a specific aspect of one sig-
naling pathway in contrast to the more
physiologically complicated in vivo effects
examined in epidemiology or other toxicologic
studies.
One unanswered question is the relation-
ship between the biologic effects observed in
these cell-based assays and inhalation exposures
in humans. The average daily intake of air
ranges from about 2 m3/day in very young
infants to about 24 m3/day in adults (Health
Canada 1995). Based on these intake rates, an
individual could be exposed to levels at which
we observe an effect in vitro and are sufficient to
elicit a response in some biologic systems
(Bateson and Schwartz 2004; Pope et al.
2004b; Vineis et al. 2004). However, an impor-
tant consideration is that uptake characteristics
are very different between a cell in culture
(likely 100%) and inhalation (much less than
100%). Whether or not there is a sustained
effect in humans remains to be determined.
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